Skip to content
DraconiticResearch
Search Sources API
186,086 studies31 sourcesUpdated 17 min ago
PreprintCC BYbioRxiv

A Compendium of 49 Experimental SBS Signatures for Decoding Human Cancer Mutational Processes

  1. 1UC San Diego

Abstract

Human cancer genomes harbor distinct mutational patterns that reflect past processes of DNA damage and repair. However, the precise attribution of these signatures to specific chemical carcinogens lacks a standardized experimental reference framework. To address this gap, we curated 4,282 genome-wide sequencing datasets from 42 model systems across five species exposed to 146 cancer-risk agents. This platform yielded 49 robust experimental single-base substitution signatures (eSS), with 28 matching 19 established COSMIC signatures and 21 defining novel mutational processes. We reconstructed 24 COSMIC signatures, assigning candidate etiologies to five signatures of unknown origin and revising two contested assignments. Pan-cancer decomposition detected four eSS-like mutational processes enriched in smokers across 4,951 tumors. Lastly, independent single-molecule sequencing of primary human organoids reproduced these profiles with high fidelity, confirming true platform-independent biological reproducibility across complex human models. This eSS repertoire provides a reference that links human mutational processes to mechanistic classes of DNA damage.

Related

  1. Correlation-aware discovery of co-occurring mutational signatures in cancer
    H. Jin, B. Geiger, D. Glodzik +2
    bioRxivPreprintAll rights reservedFull textBioinformatics & computational biologybioRxiv
  2. Deconvolution of HIV-1 Mutational Signatures Reveals Dominant and Donor-Specific APOBEC3-Associated Mutagenesis Across Anatomical Compartments
    M. Soleimanpour, N. Haghjoo, J. lehle +5
    bioRxivPreprintCC BY-NDFull textGenetics & genomicsbioRxiv
  3. An experimental evaluation of drug-induced mutational meltdown as an antiviral treatment strategy.
    Claudia Bank, Nicholas Renzette, Ping Liu +9
    Evolution; international journal of organic evolutionPeer-reviewedCC BY-NC-NDFull text39 citedGenetics & genomicsHAL
  4. Hyper-mutational processes provide a head-start for weak cancer drivers: Explaining atypical KRAS variants
    Michael D Nicholson, Ian Tomlinson
    PLOS Computational BiologyPeer-reviewedCC BYFull textGenetics & genomicsOncologyPLOSEurope PMC
  5. NGS-RFA/FRA: A High Throughput Experimental and Computational Pipeline for Selective Mutational Scanning in Parallel
    S. Tureli, T. Bestebroer, S. James +13
    bioRxivPreprintCC BY-NC-NDFull textEvolutionary biologybioRxiv
BibTeX
@misc{zhivagui2026compendium,
  title = {{A Compendium of 49 Experimental SBS Signatures for Decoding Human Cancer Mutational Processes}},
  author = {M. Zhivagui and J. N. Au and S. Sharma and P. T. Nguyen and S. Al-Azzam and J. Zhang and M. Barnes and L. B. Alexandrov},
  howpublished = {bioRxiv},
  year = {2026},
  month = aug,
  doi = {10.64898/2026.08.31.748400},
  url = {https://www.biorxiv.org/content/10.64898/2026.08.31.748400v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - A Compendium of 49 Experimental SBS Signatures for Decoding Human Cancer Mutational Processes
AU  - M. Zhivagui
AU  - J. N. Au
AU  - S. Sharma
AU  - P. T. Nguyen
AU  - S. Al-Azzam
AU  - J. Zhang
AU  - M. Barnes
AU  - L. B. Alexandrov
PY  - 2026
DA  - 2026/08/31
PB  - bioRxiv
DO  - 10.64898/2026.08.31.748400
UR  - https://www.biorxiv.org/content/10.64898/2026.08.31.748400v1
AB  - Human cancer genomes harbor distinct mutational patterns that reflect past processes of DNA damage and repair. However, the precise attribution of these signatures to specific chemical carcinogens lacks a standardized experimental reference framework. To address this gap, we curated 4,282 genome-wide sequencing datasets from 42 model systems across five species exposed to 146 cancer-risk agents. This platform yielded 49 robust experimental single-base substitution signatures (eSS), with 28 matching 19 established COSMIC signatures and 21 defining novel mutational processes. We reconstructed 24 COSMIC signatures, assigning candidate etiologies to five signatures of unknown origin and revising two contested assignments. Pan-cancer decomposition detected four eSS-like mutational processes enriched in smokers across 4,951 tumors. Lastly, independent single-molecule sequencing of primary human organoids reproduced these profiles with high fidelity, confirming true platform-independent biological reproducibility across complex human models. This eSS repertoire provides a reference that links human mutational processes to mechanistic classes of DNA damage.
ER  -